Phillip Securities Group
Please note that the Day Light Saving of Europe and US will be effective on April 1st and March 11th respectively. The trading hours for those relevant contracts will be 1 hour earlier. Any questions, please contact us at 22776677.For details, please visit our foreign futures website or contact us at 22776677.Moreover,the spread of USD/JPY is low as one pip.Please click here for details
 
  Phillip Investor Notes

15-01-2026(Thu) 14-01-2026(Wed) 13-01-2026(Tue) 12-01-2026(Mon) 09-01-2026(Fri)
Page : 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Investor Notes - Phillip Securities (HK) Ltd
Past Investor Notes  
Phillip Home Send to Friends Free Subscription Give Comments ¤¤¤åª©
12 Feb, 2026 (Thursday)

            
HENLIUS(2696)
Analysis¡G
Henlius Biotech is an international innovative biopharmaceutical company focused on developing monoclonal antibody (mAb) drugs, primarily targeting oncology (tumors) and autoimmune diseases. The company has successfully launched 6 products covering 25 indications, which have been approved for marketing in China, the United States, Europe, Canada, Australia, Indonesia, Mexico, Bolivia, and other countries/regions. Among these, 4 products have been approved in various overseas markets, covering nearly 60 countries/regions and benefiting more than 850,000 patients worldwide. Hansizhuang (serplulimab, an anti-PD-1 mAb) has been approved in over 30 countries and regions. It has received Orphan Drug Designation from regulatory authorities in the US, EU, Switzerland, and South Korea. It is the company¡¦s second product approved in the EU and the first anti-PD-1 monoclonal antibody approved in the EU for small cell lung cancer indications. Hanquyou's (trastuzumab) internationalization continues to advance steadily. Marketing authorization applications for different specifications have been approved in countries including Mexico. It has now been approved in a cumulative total of over 50 countries and regions, including the US, Europe, Canada, and Australia. Hanbeitai is approved in Mexico and the Dominican Republic. The company plans to work closely with partners such as Abbott, Europharma, Boston Oncology, LLC, and Getz Pharma to continue advancing the international market entry of Hanlikang (rituximab), Handayuan (adalimumab), and Hanbeitai.
The group¡¦s biopharmaceutical industrialization bases fully support the global supply of approved products. The Xuhui base has achieved routine global market supply, currently covering China, Europe, Latin America, Southeast Asia, India, and other markets. The Songjiang Base (Phase I) in Songjiang District, Shanghai, has obtained GMP certification from China, the US, and the EU. To meet long-term commercial capacity needs, the Songjiang Base (Phase II) (total planned land area of 200 mu) started construction in 2019. Its first and second phases have a combined design capacity of 36,000 liters and completed overall completion acceptance in August 2025.
The company currently has an R&D pipeline of approximately 50 molecules and more than 10 R&D platforms, covering a rich variety of drug modalities such as monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), fusion proteins, and small-molecule drugs. Its self-built clinical operations teams in China, the US, Australia, and other locations are advancing clinical studies in an orderly manner across nearly 30 countries/regions. Henlius is also actively expanding its pipeline through in-licensing. In June 2025, it entered into a licensing agreement with FBD Biologics Limited to obtain exclusive development, production, and commercialization rights for its fusion protein in mainland China, Hong Kong, Macau, and specific Southeast Asian countries. In August 2025, it reached a strategic cooperation with GeneQuantum Healthcare (Suzhou) to obtain development and exclusive commercialization rights for the innovative HER2-targeted ADC GQ1005 in China and specific overseas countries/regions.(I do not hold the above stock.)
Strategy¡G
Buy-in Price: $70.00, Target Price: $79.00, Cut Loss Price: $66.00


HUAMING EQUIP(002270)
Analysis¡G
The Company is a leader in the domestic transformer on load tap changer industry, with a current market share of over 90% in China and a global market share of 35%. Currently, it has formed three major business segments: tap changer, CNC equipment, and new energy power station contracting. Tap changers are mainly used for long-distance transmission of power across provincial power grids and voltage regulation and stabilization in power supply areas. In 9M2025, the Company In Q3 2025, the company achieved revenue growth of 6.9% yoy and net profit attributable to the parent company increased by 17.7% yoy. The net profit margin stood at 32.5%, up 3.14 percentage points yoy. The significant improvement in profitability was primarily driven by the higher proportion of the company's export business, which is known for its strong profitability. The company announced a profit forecast, with annual revenue expected to grow by 4.4% yoy and net profit attributable to the parent company by 15.3% yoy. The company has been expanding its overseas market presence for many years, with products now exported to over 130 countries and regions. It is currently accelerating its strategic layout in Southeast Asia, the United States, and Europe, and its international business is expected to maintain rapid growth.
Strategy¡G
Buy-in Price: $34.20, Target Price: $39.10, Cut Loss Price: $31.53



Weichai (2338 HK) - From a cyclical heavy truck enterprise to a structurally growing energy platform

Company Profile

Weichai is one of the automobile and equipment manufacturing groups with the strongest comprehensive strength in China's heavy truck industry. Based on the powertrain system including engine, axle and gearbox, the Company extends upstream components and downstream heavy trucks, and takes the lead in forklifts and intelligent warehousing. After years of development, the Company has built a synergetic development pattern of four major industrial segments including powertrain (engine, transmission, axle/hydraulics), vehicle and machinery, intelligent logistics and other segments.

Investment Summary

Performance Review: Revenue Grows Steadily, Net Profit Continues to Improve
According to Weichai Power's FY2025 third-quarter report: In the first nine months of 2025, the company reported a revenue of RMB170.57 billion, representing a year-on-year (YoY) growth of 5.3%. Net profit attributable to the parent company amounted to RMB8.88 billion, marking a YoY increase of 5.7%. The net profit after excluding non-recurring items reached RMB7.97 billion, up 3.4% YoY, reflecting steady progress in overall performance.

Looking at the results by quarter, the revenues for the first three quarters were RMB57.46 billion, RMB55.69 billion, and RMB57.42 billion, showing YoY changes of +1.9%, -0.8%, and +16.1%, respectively. Net profit attributable to the parent company was RMB2.71 billion, RMB2.93 billion, and RMB3.23 billion, reflecting YoY changes of +4.3%, -11.2%, and +29.5%, respectively. The first two quarters saw more moderate growth in net profit, while the third quarter showed a sharp increase, mainly due to fluctuations in oil and gas price differentials and policy subsidies. The domestic natural gas heavy truck industry experienced a high in the early period of 2024 followed by a decline in the later period, while 2005 saw a weak first half and a rapid recovery in the second half, driving fluctuations in the company's natural gas engine sales. Additionally, in the first half of the year, Kion incurred a one-time expense related to its efficiency plan, resulting in a negative impact of RMB480 million. After adjusting for this, the net profit attributable to the parent company in the first half of the year increased by 3.8% YoY to RMB6.13 billion.

Profitability Remains Resilient
In terms of profitability, for the first three quarters, the company's gross margin and net profit margin attributable to the parent company were 21.9% and 5.2%, respectively, largely unchanged YoY (+0.04 ppts, +0.01 ppts). The sales expense ratio for the first three quarters was 5.82%, up by 0.18 ppts YoY, the administrative expense ratio was 5.4%, up by 0.74 ppts YoY, and the R&D expense ratio was 3.62%, down by 0.21 ppts YoY.

In detail, the gross margin for the first three quarters was 22.2%, 22.1%, and 21.4%, with YoY changes of +0.12 ppts, +0.74 ppts, and -0.74 ppts, respectively. The net profit margin attributable to the parent company was 4.72%, 5.27%, and 5.63%, with YoY changes of +0.11 ppts, -0.62 ppts, and +0.58 ppts, respectively. Profitability remains resilient, primarily due to the improved profitability of subsidiaries Shaanxi Heavy Duty Truck and Kion, as well as the fluctuation in provisions, supply chain optimization, and continuous cost reduction and efficiency improvements in various stages.

Heavy Truck Industry Structural Reshuffle, Weichai remain Steady Product Advantages

In January 2025, the government introduced a subsidy policy to promote vehicle replacements, expanding the subsidy coverage to vehicles meeting the National IV emission standard and below. In March, the policy was further extended to natural gas heavy trucks, driving a gradual increase in demand for heavy trucks. The penetration rate of natural gas and new energy heavy trucks has rapidly increased under the dual influence of policy and technology. According to data from the China Association of Automobile Manufacturers (CAAM), the cumulative sales of heavy trucks in the Chinese market reached 1,145 thousand units in 2005, a YoY growth of 27%. Of this, 341 thousand units were exported, showing a YoY growth of 17.4%. The market now features a three-way division among diesel, natural gas, and new energy vehicles, with market shares of 46%, 25%, and 29%, respectively.

To align with industry trends, the company has developed multiple technological routes, including pure electric, fuel cell, and hybrid solutions. In the first three quarters, the company sold a total of 536 thousand engines, including 188 thousand heavy truck engines. By fuel type, the sales of diesel heavy truck engines were approximately 117 thousand units, while natural gas heavy truck engines accounted for around 71 thousand units. According to the First Commercial Vehicle Network, the company's new energy power system business achieved a revenue of RMB1.97 billion (RMB, the same below) in the first three quarters of 2005, marking an 84% YoY growth. Its subsidiary, Shaanxi Heavy Duty Truck, sold 109 thousand heavy trucks in the first three quarters, a YoY growth of 18%. Sales of new energy heavy trucks reached about 16 thousand units, a YoY growth of approximately 2.5 times, maintaining a leading position in the industry.

Looking ahead, the expected balanced supply-demand structure is likely to support natural gas prices at a stable and reasonable range, and the application of natural gas heavy trucks will become more widespread, with the penetration rate continuing to rise. With continued policy support, technological upgrades, and improvements in infrastructure, the market penetration of new energy heavy trucks is also expected to keep increasing. In the medium term, the positive effects of fiscal and monetary stimulus policies, along with the next phase of emission standard upgrades in the industry, will have a positive impact on heavy truck sales. Weichai leads the market share in heavy truck engines, particularly in the natural gas heavy truck engine market, with shares of 23% and 52%, respectively, and is expected to benefit first.

Accelerated Computing Infrastructure Drives Growth in Large-Bore Engine and Fuel Cell (SOFC) Businesses

With the rapid iteration of AI technology in recent years driving the acceleration of computing infrastructure, the power generation industry has experienced rapid growth. The demand for backup power engines has surged, and the company has deeply invested in multiple product forms, including diesel, natural gas, and solid oxide fuel cells (SOFC), to meet market needs. The company's large-bore engine (diesel) business has reached a certain scale and is entering a phase of rapid growth. In the first three quarters of 2005, sales exceeded 7,700 units, marking a YoY increase of over 30%. Among these, sales of products related to data centers surpassed 900 units, growing more than threefold YoY.

Regarding solid oxide fuel cells, in November, Weichai signed a manufacturing license agreement with its affiliate, Ceres, to establish production lines for batteries and stacks to be used in the stationary power generation market. Some key components will be supplied by Ceres, and the products will provide power for applications such as AI data centers, commercial buildings, and industrial parks. This means the company will have full control over the core technologies of batteries, stacks, systems, and power stations, and will be authorized to enter the global market for sales. Currently, the company has now a good order backlog in the SOFC field, with promising profit prospects.

We expect that with the rapid development of the global computing power market, the domestic supply chain will gradually mature and production capacity will steadily be released, leading to an accelerated expansion of the power generation equipment business order scale. The second growth curve is becoming increasingly clear.

Investment Thesis

As the share of profits from AIDC power generation business is expected to exceed 30% by 2030, the company is being revalued from a cyclical heavy truck enterprise to a structurally growing energy platform, with broad long-term growth potential. Overall, the company's leading position remains solid, with a clear strategy framework of "power + hydraulics + new energy". The forward-looking new businesses are opening up growth potential, and the high dividend payout ratio is expected to be maintained.

We forecast the EPS of the Company to be RMB 1.42/1.54/1.82 yuan in 2005/2006/2007. We will also revise target price to 34.6HKD (22/20/17x P/E and 2.9/2.6/2.4x P/B for 2005/2006/2007) and BUY rating. (Closing price as at 5 February)

Domestic Heavy-duty truck monthly sales and growth
"Domestic
Source: Wind, Company, Phillip Securities Hong Kong Research

Weichai Quarterly Net Profit
"Weichai
Source: Wind, Company, Phillip Securities Hong Kong Research

Historical P/E Band
"Historical
Source: Wind, Company, Phillip Securities Hong Kong Research

Financials

"Financials"
(Closing price as at 5 February)

Click here to download PDF version...




Recommendation on 12-2-2026
RecommendationBUY (Maintain)
Price on Recommendation Date$ 27.200
Suggested purchase priceN/A
Target Price$ 34.600
Writer Info
ZhangJing
(Research Analyst)
Tel: (+ 86 21-6351 2939)
Email:
zhangjing@phillip.com.cn

Local Index
       Index    Change   Change%

World Index
       Index    Change   Change%
  

A-H spread
Stock Code H share
Price
A share
Price
H share
discount


Oversea Research Reports


Investment Service Centre



Enquiry : 2277 6666 OR investornotes@phillip.com.hk
If you cannot read this e-mail in the proper format, please click here to view the web version.

Information contained herein is based on sources that Phillip Securities (Hong Kong) Limited and/or its affiliates ( the ¡§Group¡¨) believe to be accurate. The Group does not bear responsibility for any loss occasioned by reliance placed upon the contents hereof. The Group (or its employees) may have interests in relevant investment products. For details of different products¡¦ risks, please view the Risk Disclosures Statement on http://www.phillip.com.hk.

If you DO NOT wish to receive further marketing emails from us, please click HERE to opt-out.

ª©Åv©Ò¦³¡A ½¦L¥²¨s¡C

Copyright(C) 2026 Phillip Securities (HK) Ltd. All Rights Reserved.


Copyright © 2011 Phillip Securities Group. All Rights Reserved [ Risk Disclosures Statement ] [ Terms and Conditions ] [ Personal Data Policy ]